FDA Approves Tucatinib in Combination with Chemotherapy for HER2-Positive Breast Cancer

0
864

[ad_1]

FDA Approves Tucatinib in Combination with Chemotherapy for HER2-Positive Breast Cancer 1
The FDA approved tucatinib in combination with chemotherapy for the treatment of adult patients with advanced forms of HER2-positive breast cancer.

[ad_2]